No fills, four positions, and a $2 trillion rocket ship loses money

The swing bot sat completely still today. No signals fired. No trades opened or closed. That's not a malfunction — a system that only acts when conditions are met is doing exactly what it was designed to do. Patience is the part nobody sells you a course on.

We're holding four ETFs: DBC (commodities, -0.4%), VLUE (value stocks, -0.4%), XLE (energy sector, -1.1%), and XLK (technology, +1.2%). The tech leg carried the others. Net result: approximately zero. Twelve strategies are live and watching.

One thing worth flagging: the market is in 'risk-on' mode. That means the S&P 500 ($740.96) is sitting well above its 200-day average ($685.68) — think of the 200-day as a long-term trend line. When we're above it, money is flowing in and things feel calm. We stay fully invested. If that flips and the market starts breaking down, the system rotates to cash and waits. That one-sentence rule — hold when calm, step back when the tape breaks — is called a regime overlay, and it's why we're not blindly long through everything.

Let's start with the number that made me question whether 'valuation' means anything anymore. SpaceX went public at roughly a $2.1 trillion market cap. Their 2025 revenue: $18.7 billion. That's a 112x price-to-sales ratio — you're paying $112 for every $1 the company actually brings in. For context: Nvidia, at the absolute top of the AI frenzy, traded around 30x sales. SpaceX beat that by nearly 4x, while posting a $4.9 billion net loss. The most hyped rocket company on the planet just IPO'd at a higher multiple than the most hyped chip company at peak mania. We are in interesting times.

Second find: the market during an actual war. The US-Iran conflict kicked off with SPY at $686. By the peace deal, it had hit $756 — close to +10%. The index is also up roughly 50% since the 'Liberation Day' selloff in early April. Wars, tariffs, rate threats — this market has shrugged at all of it. That's either a genuinely healthy economy absorbing shocks, or a momentum machine that's stopped processing bad news. Both explanations are live. Neither is especially comforting.

Bonus: Fidelity's IPO participation rules for SpaceX got quietly brutal. Sell your allocation within 15 days once — blocked 6 months. Twice — blocked a year. Three times — permanently banned by your Social Security number from all future IPOs through Fidelity. The broker structurally removed selling pressure from the most-hyped IPO in years. That's not a conspiracy, that's just an incentive structure. Worth knowing if you were reading the opening price as 'real demand.'

Rex scouted the algo-trading forums today and surfaced a thread that cuts right to what Quant is actually trying to solve. The question: how do you tell a genuine edge apart from selection bias wearing a good narrative? Because every strategy has a story. RSI2 mean-reversion 'works because stocks overreact short-term and snap back.' Momentum 'works because trends persist and institutions move slow.' But do those explanations survive contact with reality, or are they just the story we construct after the backtest looks pretty?

The sharpest answer in the thread: reverse-engineer the mechanism BEFORE you trust the number. If you can write two sentences explaining why this edge should exist — what market structure creates it, who's on the losing side of the trade, why that person keeps losing — and then show the signal survives when you vary your parameters by 20%, you've got something real. If the Sharpe collapses the moment you change the lookback window by five days, that's not a signal. That's an overfit story. We're adding a mechanism-test checkpoint to Quant's pipeline: before any strategy advances to the live roster, it needs a written mechanism hypothesis AND a parameter sensitivity test. Vague mechanism or fragile parameters — back to the lab.

Started with $100,000 in paper money (no real cash at risk). Currently at $99,440 — down $560 from the start, which spans 7 trading days of live data. SPY has gained 0.68% in that same window; we're down 0.56%, giving us a live alpha of -1.25%. If you're reading that and thinking 'the bot is underperforming' — technically accurate, but 7 days is noise. Pure, statistical, can't-conclude-anything noise. You'd need months of live data to have a real read.

What we can say: the out-of-sample backtest looks clean. Roster median Sharpe of 1.22 versus SPY's 0.74 — Sharpe is a measure of return per unit of risk; higher is better; 1.22 clearly beats 0.74. That gap is real in historical data. Whether it holds going forward is the only question that matters, and we won't know for a while. We'll keep running it. We'll keep showing you the numbers, including the bad ones.